EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome

Maria Katsioupa iD, Islam Kourampi iD, Evangelos Oikonomou iD, Vasiliki Tsigkou iD, Panagiotis Theofilis iD, Georgios Charalambous, George Marinos iD, Ioannis Gialamas, Konstantinos Zisimos, Artemis Anastasiou, Efstratios Katsianos, Konstantinos Kalogeras iD und 4 weitere

Life · 29.09.2023 · 13 (10) · 1992

DOI: 10.3390/life13101992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 29.09.2023. Verfasst von Maria Katsioupa und 15 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Cardiology, Thoracic Diseases General Hospital "Sotiria", National and Kapodistrian University of Athens, 11527 Athens, Greece. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The burden of cardiovascular diseases and the critical role of acute coronary syndrome (ACS) in their progression underscore the need for effective diagnostic and prognostic tools. Biomarkers have emerged as crucial instruments for ACS diagnosis, risk stratification, and prognosis assessment. Among these, high-sensitivity troponin (hs-cTn) has revolutionized ACS diagnosis due to its superior sensitivity and negative predictive value. However, challenges regarding specificity, standardization, and interpretation persist. Beyond troponins, various biomarkers reflecting myocardial injury, neurohormonal activation, inflammation, thrombosis, and other pathways are being explored to refine ACS management. This review article comprehensively explores the landscape of clinically used biomarkers intricately involved in the pathophysiology, diagnosis, and prognosis of ACS (i.e., troponins, creatine kinase MB (CK-MB), B-type natriuretic peptides (BNP), copeptin, C-reactive protein (CRP), interleukin-6 (IL-6), d-dimers, fibrinogen), especially focusing on the prognostic role of natriuretic peptides and of inflammatory indices. Research data on novel biomarkers (i.e., endocan, galectin, soluble suppression of tumorigenicity (sST2), microRNAs (miRNAs), soluble oxidized low-density lipoprotein receptor-1 (sLOX-1), F2 isoprostanes, and growth differentiation factor 15 (GDF-15)) are further analyzed, aiming to shed light on the multiplicity of pathophysiologic mechanisms implicated in the evolution of ACS. By elucidating the complex interplay of these biomarkers in ACS pathophysiology, diagnosis, and outcomes, this review aims to enhance our understanding of the evolving trajectory and advancements in ACS management. However, further research is necessary to establish the clinical utility and integration of these biomarkers into routine practice to improve patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

acute coronary syndromebiomarkercoronary artery diseaseinflammationmyocardial injuryneurohormonal activationthrombosis

Autor:innen und Institutionen

  • 3rd Department of Cardiology, Thoracic Diseases General Hospital "Sotiria", National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • 1st Department of Cardiology, "Hippokration" General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Emergency Medicine, "Hippokration" General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Maria Katsioupa, Islam Kourampi, Evangelos Oikonomou, Vasiliki Tsigkou, Panagiotis Theofilis, George Marinos, Konstantinos Kalogeras

Zitieren

APA

Katsioupa, M., Kourampi, I., Oikonomou, E., Tsigkou, V., Theofilis, P., Charalambous, G., Marinos, G., Gialamas, I., Zisimos, K., Anastasiou, A., Katsianos, E., Kalogeras, K., Katsarou, O., Vavuranakis, M., Siasos, G., & Tousoulis, D. (2023). Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. Life, 13(10), 1992. https://doi.org/10.3390/life13101992

Vancouver

Katsioupa M, Kourampi I, Oikonomou E, Tsigkou V, Theofilis P, Charalambous G, et al. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. Life. 2023;13(10):1992. doi:10.3390/life13101992

BibTeX
@article{Katsioupa2023,
  author = {Katsioupa, Maria and Kourampi, Islam and Oikonomou, Evangelos and Tsigkou, Vasiliki and Theofilis, Panagiotis and Charalambous, Georgios and Marinos, George and Gialamas, Ioannis and Zisimos, Konstantinos and Anastasiou, Artemis and Katsianos, Efstratios and Kalogeras, Konstantinos and Katsarou, Ourania and Vavuranakis, Manolis and Siasos, Gerasimos and Tousoulis, Dimitris},
  title = {Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {10},
  pages = {1992},
  doi = {10.3390/life13101992}
}
Kostenlos starten →